Phenformin as prophylaxis and therapy in breast cancer xenografts
Open Access
- 23 February 2012
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 106 (6), 1117-1122
- https://doi.org/10.1038/bjc.2012.56
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Metformin Induces Both Caspase-Dependent and Poly(ADP-ribose) Polymerase-Dependent Cell Death in Breast Cancer CellsMolecular Cancer Research, 2011
- Metformin Associated With Lower Cancer Mortality in Type 2 DiabetesDiabetes Care, 2009
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast CancerJournal of Clinical Oncology, 2009
- Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27Kip1 or p21Cip1Journal of Molecular Signaling, 2008
- Characterization, chemical optimization and anti-tumor activity of a tubulin poison identified by a p53-based phenotypic screenCell Cycle, 2008
- Important role of the LKB1–AMPK pathway in suppressing tumorigenesis in PTEN-deficient miceBiochemical Journal, 2008
- Discovery, In Vivo Activity, and Mechanism of Action of a Small-Molecule p53 ActivatorCancer Cell, 2008
- Systemic Therapy for Colorectal CancerThe New England Journal of Medicine, 2005
- Role of AMP-activated protein kinase in mechanism of metformin actionJCI Insight, 2001
- Cell Cycle Regulation via p53 Phosphorylation by a 5′-AMP Activated Protein Kinase Activator, 5-Aminoimidazole- 4-Carboxamide-1-β-d-Ribofuranoside, in a Human Hepatocellular Carcinoma Cell LineBiochemical and Biophysical Research Communications, 2001